Literature DB >> 9010486

Calcein is excreted from the intestinal mucosal cell membrane by the active transport system.

T Fujita1, H Yamada, M Fukuzumi, A Nishimaki, A Yamamoto, S Muranishi.   

Abstract

In this study, we report the efflux mechanism of calcein, an organic anion, mediated by a multidrug resistance-associated protein (MRP)-like protein in the intestinal mucosal membrane. The transport of calcein from the mucosal to serosal side was decreased dose-dependently and was significantly lower than that of the opposite direction. In addition, its transport was increased in the presence of metabolic inhibitors and probenecid. Furthermore, the efflux of calcein from the intestinal cell membrane, which was preloaded with calcein acetoxymethyl ester, was predominantly observed in the mucosal side rather than in the serosal side. Its efflux to the mucosal side was inhibited by the metabolic inhibitors and probenecid, not by verapamil which is a P-glycoprotein substrate. These results indicated that the transport of calcein and possibly other organic anions across the intestinal membrane may be regulated by the MRP-like protein, but not P-glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010486     DOI: 10.1016/s0024-3205(96)00631-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Multidrug resistance transporters in the olfactory receptor neurons of Xenopus laevis tadpoles.

Authors:  Ivan Manzini; Detlev Schild
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

2.  Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake.

Authors:  H Gutmann; G Fricker; M Török; S Michael; C Beglinger; J Drewe
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

3.  No evidence for the involvement of the multidrug resistance-associated protein and/or the monocarboxylic acid transporter in the intestinal transport of fluvastatin in the rat.

Authors:  A Lindahl; S Frid; A L Ungell; H Lennernas
Journal:  AAPS PharmSci       Date:  2000

4.  Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats.

Authors:  Kazumasa Naruhashi; Ikumi Tamai; Natsuko Inoue; Hiromi Muraoka; Yoshimichi Sai; Nagao Suzuki; Akira Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

5.  Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.

Authors:  R H Stephens; C A O'Neill; J Bennett; M Humphrey; B Henry; M Rowland; G Warhurst
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Characterization and application of a vinblastine-selected CACO-2 cell line for evaluation of p-glycoprotein.

Authors:  Dennis A Laska; Jack O Houchins; Susan E Pratt; Jeffery Horn; Xialong Xia; Brenda R Hanssen; Daniel C Williams; Anne H Dantzig; Terry Lindstrom
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Jul-Aug       Impact factor: 2.416

7.  Is cyclosporine A transport inhibited by pravastatin via multidrug resistant protein 2?

Authors:  Ryuji Kato; Mami Nishide; Chihiro Kozu; Asuka Iwamoto; Kazuya Urashima; Kaoru Suzuki; Yoshio Ijiri; Tetsuya Hayashi; Kazuhiko Tanaka
Journal:  Eur J Clin Pharmacol       Date:  2009-10-13       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.